Celiac Drugs Market- Overview

The global celiac drugs market is present worth USD 703.54 million and is poised to amplify with a CAGR of 16.95% over 2023-2033, thereby amassing a valuation of USD 2462.1 million by end of the assessment timeframe. Celiac disease is referred to as a type of autoimmune disorder which gets trigged by the consumption of gluten based products. The ailment primarily causes inflammation which ends up damaging the lining of the small intestine. The disease also prevents the body from absorbing vital nutrients. People affected with celiac disorder face symptoms such as diarrhea, fatigue, bloating, anemia, wind, and osteoporosis.

Report Scope

Report Attributes	Description
Market Size in 2022	USD 703.54 Million
Market Forecast in 2033	USD 8,160 Million
CAGR % 2023-2033	16.95%
Base Year	2022
Historic Data	2019-2021
Forecast Period	2023-2033
Report USP	Country  and regional estimates, key developments  by countries and companies  market share by countries
Segments Covered	Type, application, distribution channel, route  of administration and end user
Regional Scope	North America, Europe, APAC, South America and Middle East and Africa
Country Scope	U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria
Key Companies	F. Hoffmann-La Roche, Merck & Co., Inc., Johnson & Johnson, BiolineRx Ltd., Pfizer Inc., Innovate Biopharmaceuticals, ImmusanT, Inc., Novartis AG, Bristol-Myers Squibb Company, and Immunomedics, Inc.

The growing pervasiveness of celiac disease, increasing healthcare expenditure, and rising R&D investments in the field are primarily augmenting the outlook of this marketplace. Furthermore, rising focus of pharmaceutical and healthcare research bodies to develop efficient drugs in the field is creating lucrative opportunities for the industry vertical to prosper.

Also, surging health cognizance of the masses, booming biopharmaceutical sector, and increasing geriatric base across the globe are adding momentum to the progression of this business sphere. Moreover, increasing consumption of gluten based food and unavailability of effective drugs for the disease is paving a way for the industry to amass significant gains.

On the contrary, significant regulatory standards pertaining to drug approvals, coupled with rising concerns regarding the side effects of celiac drugs are hindering the remuneration scope of this marketplace.

Celiac Drugs Market- Key trends

Extensive R&D activities in the field to bolster industry growth

There has been a steep rise in the number of R&D activities pertaining to the development of efficient drugs to treat celiac disorder. The related bodies or organizations are working tirelessly to get a breakthrough in this field. Although, as of now there is not specific drugs solely made to treat this disorder, but some biological therapies and immunosuppresants have been developed as an option to cure celiac disorder. This in turn is stimulating the overall dynamics of this marketplace.

Growing consumption of gluten-based products is aiding market expansion

A wide array of consumables including cereals, breads, pasta, baked goods, soup, crackers, and many grain forms contain gluten. Most of the listed edibles are a part of our regular diet which in turn increases our gluten intake on a daily basis. It is a fact that there is no approved diagnostic procedure to determine the presence of the disease. Therefore, many cases go undiagnosed until the symptoms reach an ultimate level. These factors are augmenting the outlook of this business sphere.

Celiac Drugs Market- Segmental Assessment

Celiac disease is an autoimmune disorder caused by the ingestion of gluten, a protein found in wheat, barley, and rye. The current treatment for celiac disease is a strict gluten-free diet, which can be difficult to maintain and can have a significant impact on patients' quality of life.

There is currently no cure for celiac disease, and the development of new treatments, including biological drugs, is an area of active research. Biological drugs are a type of therapy that targets specific molecules or cells involved in the immune response, and have the potential to offer more effective and targeted treatment options for celiac disease.

Several biological drugs are being developed for the treatment of celiac disease, including monoclonal antibodies that target the immune cells involved in the inflammatory response triggered by gluten ingestion. These drugs have shown promising results in clinical trials, with some studies suggesting that they can reduce inflammation and improve symptoms in patients with celiac disease.

The demand for biological drugs for celiac disease is driven by the need for more effective and targeted treatment options that can improve patient outcomes and quality of life. The prevalence of celiac disease is increasing worldwide, and there is a growing need for new therapies that can address the unmet medical needs of patients with this condition.

Overall, the demand for biological drugs for celiac disease is expected to continue to grow in the coming years, driven by the increasing prevalence of the disease, the need for more effective treatments, and the ongoing research and development efforts in this area.

Celiac Drugs Market-Geographical Landscape

The primary regions constituting the geographical ambit of this business sphere are North America, Middle East & Africa, Europe, Asia Pacific, and Latin America. Among these, Asia Pacific is projected to capture a substantial revenue share over the forecast period of 2022-2030. This is attributable to the increasing geriatric population base, rising gluten consumption, and surging healthcare expenditure.

Germany is one of the largest markets for celiac disease drugs in Europe. The demand for celiac drugs in Germany is driven by various factors.

The prevalence of celiac disease in Germany is relatively high, with an estimated 1% of the population affected. This has led to a significant burden on the healthcare system and a growing need for effective and targeted treatments.

The current standard of care for celiac disease in Germany is a strict gluten-free diet, which can be difficult to maintain and may not be effective for all patients. As a result, there is a growing interest in the development of new treatments, including biological drugs, that can offer more effective and targeted therapy options.

Several clinical trials of biological drugs for celiac disease are currently underway in Germany, including trials of monoclonal antibodies that target the immune cells involved in the inflammatory response triggered by gluten ingestion. These drugs have shown promising results in early studies and may offer a new approach to the treatment of celiac disease.

The demand for celiac drugs in Germany is also driven by the country's strong healthcare infrastructure, which supports the development and adoption of innovative therapies. Germany has a well-established regulatory framework for drug development and approval, as well as a robust healthcare reimbursement system that covers a wide range of therapies.

Overall, the demand for celiac drugs in Germany is expected to continue to grow in the coming years, driven by the increasing prevalence of the disease, the need for more effective treatments, and the ongoing research and development efforts in this area.

Celiac Drugs Market-Competitive Intelligence

The prominent players characterizing the competitive terrain of this industry vertical are F. Hoffmann-La Roche, Merck & Co., Inc., Johnson & Johnson, BiolineRx Ltd., Pfizer Inc., Innovate Biopharmaceuticals, ImmusanT, Inc., Novartis AG, Bristol-Myers Squibb Company, and Immunomedics, Inc.

Notably, in August 2019, Innovate Biopharmaceuticals, Inc. announced the enrollment of the first patient in its Phase III clinical trial of a potential celiac disease drug named CeD LA 3001.

Why to buy this Report?

Market research: The report provides valuable insights into market trends, growth opportunities, and competitive landscapes. By reading a technology report, businesses and investors can gain a better understanding of the market they are operating in or considering entering, and make more informed decisions based on data and analysis.

Competitive analysis: The report reports provide detailed information on competitors' strengths, weaknesses, and strategies, which can help businesses identify potential threats and opportunities in the market.

Innovation: The report provides insights into emerging technologies and trends, which can help businesses stay up-to-date with the latest developments and make informed decisions about where to invest their resources.

Due diligence: The report can be used by investors and acquirers as part of their due diligence process when considering investing in or acquiring a technology company. These reports can provide valuable information on the company's financials, technology, market position, and other key factors.

By Type

• Biological drugs

• Immunosuppresants

• Corticosteroids

By Application

• Classical celiac disease

• Non- classical celiac disease

• Silent celiac disease

By Route of administration

• Topical

• Parenteral

• Oral

• Others

By End User

• Hospitals

• Specialty clinics

• Home healthcare

• Others

By Distribution channel

• Direct tender

• Hospital pharmacy

• Retail pharmacy

• Online pharmacy

• Others

Regions

North America

·         U.S.

·         Canada

·         Mexico

Europe

·         Germany

·         U.K.

·         France

·         Italy

·         Spain

·         Russia

·         Rest of Europe

Asia Pacific

·         China

·         Japan

·         India

·         Australia

·         Korea

·         Rest of Asia pacific

South America

·         Brazil

·         Argentina

·         Colombia

·         Rest of South America

Middle East & Africa

·         UAE

·         Saudi Arabia

·         Egypt

·         Oman

·         Kuwait

·         South Africa

·         Rest of MEA

1.     Global Celiac Drugs Market Introduction and Market Overview

1.1.  Objectives of the Study

1.2.  Celiac Drugs Market Definition & Description

1.3.  Global Celiac Drugs Market Scope and Market Estimation

1.3.1.     Global Celiac Drugs Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023-2033)

1.3.2.     Global Celiac Drugs Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019-2033

1.4.  Market Segmentation

1.4.1.     Type of Global Celiac Drugs Market

1.4.2.     Application of Global Celiac Drugs Market

1.4.3.     Route of administration of Global Celiac Drugs Market

1.4.4.     End User of Global Celiac Drugs Market

1.4.5.     Distribution Channel of Global Celiac Drugs Market

1.4.6.     Region of Global Celiac Drugs Market

 

2.     Executive Summary

2.1.  Global Celiac Drugs Market Industry Trends under COVID-19 Outbreak

2.1.1.     Global COVID-19 Status Overview

2.1.2.     Influence of COVID-19 Outbreak on Global Celiac Drugs Market Industry Development

2.2.  Market Dynamics

2.2.1.     Drivers

2.2.2.     Limitations

2.2.3.     Opportunities

2.2.4.     Impact Analysis of Drivers and Restraints

2.3.  Pricing Trends Analysis & Average Selling Prices (ASPs)

2.4.  Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.5.  Porter’s Five Forces Analysis

2.5.1.     Bargaining Power of Suppliers

2.5.2.     Bargaining Power of Buyers

2.5.3.     Threat of Substitutes

2.5.4.     Threat of New Entrants

2.5.5.     Competitive Rivalry

2.6.  Value Chain / Ecosystem Analysis

2.7.  PEST Analysis

2.8.  Russia-Ukraine War Impacts Analysis

2.9.  Economic Downturn Analysis

2.10. Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

 

3.     Global Celiac Drugs Market Estimates & Historical Trend Analysis (2020 - 2022)

 

4.     Global Celiac Drugs Market Estimates & Forecast Trend Analysis, by Type

4.1.  Global Celiac Drugs Market Revenue (US$ Mn) Estimates and Forecasts, by Installation, 2023 to 2033

4.1.1.     Biological drugs

4.1.2.     Immunosuppresants

4.1.3.     Corticosteroids

 

5.     Global Celiac Drugs Market Estimates & Forecast Trend Analysis, by Application

5.1.  Global Celiac Drugs Market Revenue (US$ Mn) Estimates and Forecasts, by Installation, 2023 to 2033

5.1.1.     Classical celiac disease

5.1.2.     Non- classical celiac disease

5.1.3.     Silent celiac disease

 

6.     Global Celiac Drugs Market Estimates & Forecast Trend Analysis, by Route of administration

6.1.  Global Celiac Drugs Market Revenue (US$ Mn) Estimates and Forecasts, by Installation, 2023 to 2033

6.1.1.     Topical

6.1.2.     Parenteral

6.1.3.     Oral

 

7.     Global Celiac Drugs Market Estimates & Forecast Trend Analysis, by End-User

7.1.  Global Celiac Drugs Market Revenue (US$ Mn) Estimates and Forecasts, by Installation, 2023 to 2033

7.1.1.     Hospitals

7.1.2.     Specialty clinics

7.1.3.     Home healthcare

 

8.     Global Celiac Drugs Market Estimates & Forecast Trend Analysis, by Distribution Channel

8.1.  Global Celiac Drugs Market Revenue (US$ Mn) Estimates and Forecasts, by Installation, 2023 to 2033

8.1.1.     Direct tender

8.1.2.     Hospital pharmacy

8.1.3.     Retail pharmacy

8.1.4.     Online pharmacy

            

9.     Global Celiac Drugs Market Estimates & Forecast Trend Analysis, by Region

9.1.  Global Celiac Drugs Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2023 to 2033

9.1.1.     North America

9.1.2.     Europe

9.1.3.     Asia Pacific

9.1.4.     Middle East & Africa

9.1.5.     South America

 

10.  North America Celiac Drugs Market: Estimates & Forecast Trend Analysis

10.1.    North America Celiac Drugs Market Assessments & Key Findings

10.1.1.  North America Celiac Drugs Market Introduction

10.1.2.  North America Celiac Drugs Market Size Estimates and Forecast (US$ Million) (2023 to 2033)

10.1.2.1.   By Type

10.1.2.2.   By Application

10.1.2.3.   By Route of administration

10.1.2.4.   By End User

10.1.2.5.   By Distribution Channel

10.1.2.6.   By Country

10.1.2.6.1.            The U.S.

10.1.2.6.2.            Canada

10.1.2.6.3.            Mexico

 

11.  Europe Celiac Drugs Market: Estimates & Forecast Trend Analysis

11.1. Europe Celiac Drugs Market Assessments & Key Findings

11.1.1.  Europe Celiac Drugs Market Introduction

11.1.2.  Europe Celiac Drugs Market Size Estimates and Forecast (US$ Million) (2023 to 2033)

11.1.2.1.   By Type

11.1.2.2.   By Application

11.1.2.3.   By Route of administration

11.1.2.4.   By End User

11.1.2.5.   By Distribution Channel

11.1.2.6.   By Country

11.1.2.6.1.            Germany

11.1.2.6.2.            U.K.

11.1.2.6.3.            France

11.1.2.6.4.            Italy

11.1.2.6.5.            Spain

11.1.2.6.6.            Russia

11.1.2.6.7.            Rest of Europe

 

12.  Asia Pacific Celiac Drugs Market: Estimates & Forecast Trend Analysis

12.1. Asia Pacific Market Assessments & Key Findings

12.1.1.  Asia Pacific Celiac Drugs Market Introduction

12.1.2.  Asia Pacific Celiac Drugs Market Size Estimates and Forecast (US$ Million) (2023 to 2033)

12.1.2.1.   By Type

12.1.2.2.   By Application

12.1.2.3.   By Route of administration

12.1.2.4.   By End User

12.1.2.5.   By Distribution Channel

12.1.2.6.   By Country

12.1.2.6.1.            China

12.1.2.6.2.            Japan

12.1.2.6.3.            India

12.1.2.6.4.            Australia

12.1.2.6.5.            South Korea

12.1.2.6.6.            ASEAN

12.1.2.6.7.            Rest of Asia Pacific

 

13.  Middle East & Africa Celiac Drugs Market: Estimates & Forecast Trend Analysis

13.1. Middle East & Africa Market Assessments & Key Findings

13.1.1.  Middle East & Africa Celiac Drugs Market Introduction

13.1.2.  Middle East & Africa Celiac Drugs Market Size Estimates and Forecast (US$ Million) (2023 to 2033)

13.1.2.1.   By Type

13.1.2.2.   By Application

13.1.2.3.   By Route of administration

13.1.2.4.   By End User

13.1.2.5.   By Distribution Channel

13.1.2.6.   By Country

13.1.2.6.1.              U.A.E.

13.1.2.6.2.              Saudi Arabia

13.1.2.6.3.              Egypt

13.1.2.6.4.              South Africa

13.1.2.6.5.              Rest of Middle East & Africa

 

14.  South America Celiac Drugs Market: Estimates & Forecast Trend Analysis

14.1. South America Market Assessments & Key Findings

14.1.1.  South America Celiac Drugs Market Introduction

14.1.2.  South America Celiac Drugs Market Size Estimates and Forecast (US$ Million) (2023 to 2033)

14.1.2.1.   By Type

14.1.2.2.   By Application

14.1.2.3.   By Route of administration

14.1.2.4.   By End User

14.1.2.5.   By Distribution Channel

14.1.2.6.   By Country

14.1.2.6.1.            Brazil

14.1.2.6.2.            Argentina

14.1.2.6.3.            Colombia

14.1.2.6.4.            Rest of South America

 

15.  Competition Landscape

15.1. Global Celiac Drugs Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

15.2. Global Celiac Drugs Market Concentration & Company Market Shares (%) Analysis, 2022

 

16.  Company Profiles

16.1.    F. Hoffmann-La Roche

16.1.1.     Company Overview & Key Stats

16.1.2.     Financial Performance & KPIs

16.1.3.     Product Portfolio

16.1.4.     Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

16.2.    Merck & Co. Inc.

16.3.    Johnson & Johnson

16.4.    BiolineRx Ltd.

16.5.    Pfizer Inc.

16.6.    Innovate Biopharmaceuticals

16.7.    ImmusanT Inc.

16.8.    Novartis AG

16.9.    Bristol-Myers Squibb Company

16.10.  Immunomedics Inc

16.11.  Others**

 

17.  Research Methodology

17.1. External Transportations / Databases

17.2. Internal Proprietary Database

17.3. Primary Research

17.4. Secondary Research

17.5. Assumptions

17.6. Limitations

17.7. Report FAQs

 

18.  Research Findings & Conclusion 

Quality Assurance Process

1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process

We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:

• Project kickoff meeting with client
• Conduct frequent client communications
• Form project steering committee
• Assign a senior SR executive as QA Executive
• Conduct internal editorial & quality reviews of project deliverables
• Certify project staff in SR methodologies & standards
• Monitor client satisfaction
• Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).

Solution

The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.

Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.

Conclusion

The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.